Evolution of first-line glaucoma therapy, 2007–2018: a population-based analysis
- 6 December 2022
- journal article
- research article
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 59 (2) , 89-95
Abstract
No abstract availableKeywords
Funding Information
- Institute for Clinical Evaluative Sciences
- Kementerian Kesihatan Malaysia
- Ministry of Health, Ontario
- Ministry of Long-Term Care
This publication has 31 references indexed in Scilit:
- Selective Laser Trabeculoplasty Versus Medical Therapy as Initial Treatment of GlaucomaJournal of Glaucoma, 2012
- Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control studyBMJ, 2012
- Comparison of Newly Diagnosed Ocular Hypertension and Open-Angle Glaucoma: Ocular Variables, Risk Factors, and Disease SeverityJournal of Ophthalmology, 2012
- Efficiency of Glaucoma Drug Regulation in 5 European CountriesJournal of Glaucoma, 2011
- Shared care in glaucoma: a national study of secondary care lead schemes in EnglandEye, 2009
- The epidemiology of medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994 to 2003British Journal of Ophthalmology, 2006
- A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucomaBritish Journal of Ophthalmology, 2005
- Glaucoma treatment in Australia: changing patterns of therapy 1994–2003Clinical & Experimental Ophthalmology, 2004
- Five‐year follow up of selective laser trabeculoplasty in Chinese eyesClinical & Experimental Ophthalmology, 2004
- The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health careBritish Journal of Ophthalmology, 2002